Marosvári I, Neubauer K
Acta Paediatr Hung. 1985;26(4):297-302.
The effect of flumecinolone, a new drug with enzyme inductor properties, on non-haemolytic hyperbilirubinaemia of term and premature newborns has been investigated. Prophylactic treatment with the drug prevented the development of severe hyperbilirubinaemia. Alone or in combination with phototherapy, flumecinolone inhibited the steep rise of serum bilirubin in premature infants. A similar effect has been shown in term babies with haematomas. The new drug is void of all side-effects of phenobarbital.
已对具有酶诱导特性的新药氟米松龙对足月儿和早产儿非溶血性高胆红素血症的影响进行了研究。用该药物进行预防性治疗可预防严重高胆红素血症的发生。单独使用或与光疗联合使用时，氟米松龙可抑制早产儿血清胆红素的急剧上升。在患有血肿的足月儿中也显示出类似的效果。这种新药没有苯巴比妥的所有副作用。
